Atlas Trials

Pharmacokinetics/Safety of Miltefosine Allometric Dose for the Treatment of Visceral Leishmaniasis in Children in Eastern Africa

Clinical trial NCT02431143 · COMPLETED

Trial details

NCT number
NCT02431143
Sponsor
Drugs for Neglected Diseases
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Visceral Leishmaniasis
Start date
2015-05-01
Primary completion
2016-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.